Diana Saville is the Director of the Global Leadership Incubator, in partnership with the Prime Minister of the Tibetan Government-in-Exile, the H.H. Dalai Lama, and the Central Tibetan Administration to provide educational scholarships for Tibetan students to study in the United States.
Diana leads communications and development for the GLI, and is involved in student selection, GLI scholar training, and in managing the GLI application process.
Diana is also the Chief Innovation Officer of the Angiogenesis Foundation, a nonprofit organization created to re-conceptualize health and fighting disease through angiogenesis, the process used by the body to grow and maintain blood vessels. Diana develops program strategies and value-based social enterprise solutions for advancing health initiatives aimed at prevention of major diseases, such as cancer, vision loss, and chronic wounds. She works with leaders in the healthcare industry, NGOs, patient advocates, and medical associations to align interests and create high impact collaborations supporting the Angiogenesis Foundation’s mission. She has served as a delegate at the Clinton Global Initiative, at Patient-Centered Outcomes Research Institute training programs, and at strategic advocacy summits across Europe and North America.
Diana is an expert on communicating complex concepts related to science and social entrepreneurship. She received her undergraduate degree with honors in Biochemical Sciences from Harvard College, and began working with university professors and Pixar animators to visualize molecular phenomena while pursuing a Ph.D. in Molecular and Cellular Biology at the University of California, Berkeley.
Diana's creative work has been featured in the Nobel Museum in Stockholm, the Museum of Modern Art in New York and at TEDMED. Diana’s visual media has received the Award of Excellence from the American Association of Medical Illustrators. She has played a creative role in successful initiatives at the American Museum of Natural History, Harvard University, Harvard Medical School, Massachusetts Institute of Technology, New York University, the U.S. Air Force, and Lawrence Berkeley National Laboratories.